Interaction of JAK with steroid receptor function
暂无分享,去创建一个
[1] M. Cleary,et al. Minireview: Obesity and breast cancer: the estrogen connection. , 2009, Endocrinology.
[2] A. Kornblihtt,et al. Progestins Induce Transcriptional Activation of Signal Transducer and Activator of Transcription 3 (Stat3) via a Jak- and Src-Dependent Mechanism in Breast Cancer Cells , 2005, Molecular and Cellular Biology.
[3] M. Krasil'nikov,et al. Signal transducer and activator of transcription-3 and phosphatidylinositol-3 kinase as coordinate regulators of melanoma cell response to glucocorticoid hormones , 2002, The Journal of Steroid Biochemistry and Molecular Biology.
[4] S. Collins. The role of retinoids and retinoic acid receptors in normal hematopoiesis , 2002, Leukemia.
[5] N. Moore,et al. Steroid receptor phosphorylation: a key modulator of multiple receptor functions. , 2007, Molecular endocrinology.
[6] T. Suga,et al. Effects of testosterone, hypophysectomy and growth hormone treatment on clofibrate induction of peroxisomal beta-oxidation in female rat liver. , 1994, Biochemical pharmacology.
[7] O. Silvennoinen,et al. The Janus kinases (Jaks) , 2004, Genome Biology.
[8] L. Ivashkiv,et al. Inhibition of IL-2-induced Jak-STAT signaling by glucocorticoids. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[9] E. Levin. Minireview: Extranuclear steroid receptors: roles in modulation of cell functions. , 2011, Molecular endocrinology.
[10] N. Weigel,et al. Ligand-independent activation of steroid hormone receptors , 1998, Journal of Molecular Medicine.
[11] Béatrice Desvergne,et al. From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions. , 2006, Progress in lipid research.
[12] Neil J. McKenna,et al. Combinatorial Control of Gene Expression by Nuclear Receptors and Coregulators , 2002, Cell.
[13] C. Lange. Integration of progesterone receptor action with rapid signaling events in breast cancer models , 2008, The Journal of Steroid Biochemistry and Molecular Biology.
[14] J. Rajasingh,et al. 1,25 Dihydroxyvitamin-D3 modulates JAK-STAT pathway in IL-12/IFNgamma axis leading to Th1 response in experimental allergic encephalomyelitis. , 2006, Journal of neuroscience research.
[15] J. Peters,et al. Role of PPAR alpha in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator Wy-14,643. , 1997, Carcinogenesis.
[16] Heather J. Lee,et al. Regulation of growth hormone signaling by selective estrogen receptor modulators occurs through suppression of protein tyrosine phosphatases. , 2007, Endocrinology.
[17] J. Parker,et al. All-trans-retinoic acid effects the growth, differentiation and apoptosis of normal human myeloid progenitors derived from purified CD34+ bone marrow cells , 2000, Leukemia.
[18] U. Panzer,et al. 15-deoxy-Delta12,14-prostaglandin J2 inhibits INF-gamma-induced JAK/STAT1 signalling pathway activation and IP-10/CXCL10 expression in mesangial cells. , 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[19] E. Gelmann,et al. Molecular biology of the androgen receptor. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] M. Davidson. Effect of growth hormone on carbohydrate and lipid metabolism. , 1987, Endocrine reviews.
[21] D. Schubert,et al. Synergistic Effect of Retinoic Acid and Cytokines on the Regulation of Glial Fibrillary Acidic Protein Expression , 2010, The Journal of Biological Chemistry.
[22] T. Hoang,et al. Impaired granulocytic differentiation in vitro in hematopoietic cells lacking retinoic acid receptors alpha1 and gamma. , 1998, Blood.
[23] Carolyn L. Smith,et al. Intracellular signaling pathways: nongenomic actions of estrogens and ligand-independent activation of estrogen receptors. , 2001, Frontiers in bioscience : a journal and virtual library.
[24] W. Kraus,et al. A Global View of Transcriptional Regulation by Nuclear Receptors: Gene Expression, Factor Localization, and DNA Sequence Analysis , 2008, Nuclear receptor signaling.
[25] M. Murray,et al. Phospho‐STAT5 accumulation in nuclear fractions from vitamin A‐deficient rat liver , 2005, FEBS letters.
[26] C. Geserick,et al. The role of DNA response elements as allosteric modulators of steroid receptor function , 2005, Molecular and Cellular Endocrinology.
[27] John A Cidlowski,et al. Mechanisms of glucocorticoid receptor action in noninflammatory and inflammatory cells. , 2004, Proceedings of the American Thoracic Society.
[28] M. Marrero,et al. Regulation of angiotensin II-induced JAK2 tyrosine phosphorylation: roles of SHP-1 and SHP-2. , 1998, American journal of physiology. Cell physiology.
[29] P. Leclerc,et al. Mediators of the JAK/STAT Signaling Pathway in Human Spermatozoa1 , 2011, Biology of reproduction.
[30] C. Lange,et al. Hypothesis: Progesterone primes breast cancer cells for cross-talk with proliferative or antiproliferative signals. , 1999, Molecular endocrinology.
[31] Ji-ping Wang,et al. Estrogen utilization of IGF-1-R and EGF-R to signal in breast cancer cells , 2010, The Journal of Steroid Biochemistry and Molecular Biology.
[32] Zhentao Zhang,et al. 1,25 dihydroxyvitamin D-mediated orchestration of anticancer, transcript-level effects in the immortalized, non-transformed prostate epithelial cell line, RWPE1 , 2010, BMC Genomics.
[33] N. Binart,et al. Transcriptional Control of Adrenal Steroidogenesis , 2011, The Journal of Biological Chemistry.
[34] P. Kelly,et al. The Prolactin/Growth Hormone Receptor Family: Structure/Function Relationships , 2004, Journal of Mammary Gland Biology and Neoplasia.
[35] D. Waxman,et al. Cross-talk between Janus Kinase-Signal Transducer and Activator of Transcription (JAK-STAT) and Peroxisome Proliferator-activated Receptor-α (PPARα) Signaling Pathways , 1999, The Journal of Biological Chemistry.
[36] W. Farrar,et al. Transcriptional crosstalk between nuclear receptors and cytokine signal transduction pathways in immunity. , 2004, Cellular & molecular immunology.
[37] D. Waxman,et al. Sex-dependent expression and clofibrate inducibility of cytochrome P450 4A fatty acid omega-hydroxylases. Male specificity of liver and kidney CYP4A2 mRNA and tissue-specific regulation by growth hormone and testosterone. , 1992, The Journal of biological chemistry.
[38] R. Evans,et al. The RXR heterodimers and orphan receptors , 1995, Cell.
[39] G. Beatson. On the Treatment of Inoperable Cases of Carcinoma of the Mamma: Suggestions for a New Method of Treatment, with Illustrative Cases , 1896, Transactions. Medico-Chirurgical Society of Edinburgh.
[40] A. Verma,et al. Jak family of kinases in cancer , 2003, Cancer and Metastasis Reviews.
[41] D. Mayer,et al. Janus kinase 2--a novel negative regulator of estrogen receptor α function. , 2012, Cellular signalling.
[42] Tatsuo Kanda,et al. Involvement of interleukin-6 and androgen receptor signaling in pancreatic cancer. , 2010, Genes & cancer.
[43] K. Sjögren,et al. Estrogen inhibits GH signaling by suppressing GH-induced JAK2 phosphorylation, an effect mediated by SOCS-2 , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[44] S. Bulun,et al. Aromatase P450 Gene Expression in Human Adipose Tissue. ROLE OF A Jak/STAT PATHWAY IN REGULATION OF THE ADIPOSE-SPECIFIC PROMOTER (*) , 1995, The Journal of Biological Chemistry.
[45] Very-low-density lipoprotein mediates transcriptional regulation of aldosterone synthase in human adrenocortical cells through multiple signaling pathways , 2012, Cell and Tissue Research.
[46] L. Barouch,et al. Leptin signaling and obesity: cardiovascular consequences. , 2007, Circulation research.
[47] D. Harrison,et al. The JAK/STAT signaling pathway , 2004, Journal of Cell Science.
[48] A. Akoum,et al. Induction of human sperm capacitation and protein tyrosine phosphorylation by endometrial cells and interleukin-6. , 2005, Molecular human reproduction.
[49] C. Croce,et al. Epigenetically deregulated microRNA-375 is involved in a positive feedback loop with estrogen receptor alpha in breast cancer cells. , 2010, Cancer research.
[50] J. Frasor,et al. PRL-induced ERalpha gene expression is mediated by Janus kinase 2 (Jak2) while signal transducer and activator of transcription 5b (Stat5b) phosphorylation involves Jak2 and a second tyrosine kinase. , 2001, Molecular endocrinology.
[51] S. Collins,et al. IL-3-induced enhancement of retinoic acid receptor activity is mediated through Stat5, which physically associates with retinoic acid receptors in an IL-3-dependent manner. , 2002, Blood.
[52] J. Rajasingh,et al. 1,25 dihydroxyvitamin‐D3 modulates JAK–STAT pathway in IL‐12/IFNγ axis leading to Th1 response in experimental allergic encephalomyelitis , 2006 .
[53] Izumi V. Hinkson,et al. Androgen-sensitive microsomal signaling networks coupled to the proliferation and differentiation of human prostate cancer cells. , 2011, Genes & cancer.
[54] Marcel Garcia,et al. Estrogens and their receptors in breast cancer progression: a dual role in cancer proliferation and invasion. , 2004, Critical reviews in oncology/hematology.
[55] N. Krett,et al. Mechanisms of glucocorticoid-mediated apoptosis in hematological malignancies. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[56] J. Frasor,et al. Prolactin regulation of estrogen receptor expression , 2003, Trends in Endocrinology & Metabolism.
[57] A. Yoshimura,et al. Interaction and Functional Interference of Glucocorticoid Receptor and SOCS1* , 2008, Journal of Biological Chemistry.
[58] K. Umesono,et al. A Unified Nomenclature System for the Nuclear Receptor Superfamily , 1999, Cell.
[59] A. Giordano,et al. Leptin signaling in breast cancer: An overview , 2008, Journal of cellular biochemistry.
[60] A. Sainsbury,et al. Glucocorticoids as Counterregulatory Hormones of Leptin: Toward an Understanding of Leptin Resistance , 1997, Diabetes.
[61] K. Umesono,et al. The nuclear receptor superfamily: The second decade , 1995, Cell.
[62] M. Maggiolini,et al. The unfolding stories of GPR30, a new membrane-bound estrogen receptor. , 2010, The Journal of endocrinology.
[63] C. Johnston. Franz Volhard Lecture. Renin-angiotensin system: a dual tissue and hormonal system for cardiovascular control. , 1992, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.
[64] T. Hoang,et al. Impaired Granulocytic Differentiation In Vitro in Hematopoietic Cells Lacking Retinoic Acid Receptors α1 and γ , 1998 .
[65] T. Pineau,et al. Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators , 1995, Molecular and cellular biology.
[66] A. Moliterno,et al. Janus kinase inhibitors: an update on the progress and promise of targeted therapy in the myeloproliferative neoplasms , 2011, Current opinion in oncology.
[67] T. Sugiyama,et al. Aldosterone induces angiotensin converting enzyme gene expression via a JAK2-dependent pathway in rat endothelial cells. , 2005, Endocrinology.
[68] L. Haldosen,et al. 1α,25-Dihydroxyvitamin D3 Inhibits GH-induced Expression of SOCS-3 and CIS and Prolongs Growth Hormone Signaling via the Janus Kinase (JAK2)/Signal Transducers and Activators of Transcription (STAT5) System in Osteoblast-like Cells* , 2002, The Journal of Biological Chemistry.
[69] M. Rieder,et al. Regulation of cytokine and cytokine receptor expression by glucocorticoids , 1996, Journal of leukocyte biology.
[70] R. Ray,et al. Hepatitis C Virus Core Protein Augments Androgen Receptor-Mediated Signaling , 2008, Journal of Virology.
[71] W. Leonard,et al. Jaks and STATs: biological implications. , 1998, Annual review of immunology.
[72] K. Eguchi,et al. Rapid Inhibition of Leptin Signaling by Glucocorticoids in Vitro and in Vivo* , 2004, Journal of Biological Chemistry.
[73] K. Dawson,et al. Janus Kinase 2 and Calcium Are Required for Angiotensin II-dependent Activation of Steroidogenic Acute Regulatory Protein Transcription in H295R Human Adrenocortical Cells* , 2003, Journal of Biological Chemistry.
[74] N. Bruchovsky,et al. Activation of the Androgen Receptor N-terminal Domain by Interleukin-6 via MAPK and STAT3 Signal Transduction Pathways* , 2002, The Journal of Biological Chemistry.
[75] J. Kovarik,et al. JAK/STAT signaling pathways and cancer. Janus kinases/signal transducers and activators of transcription. , 2002, Neoplasma.
[76] Thorsten Heinzel,et al. Nuclear receptors: overview and classification. , 2004, Current drug targets. Inflammation and allergy.
[77] N. Binart,et al. Reproductive role of prolactin. , 2007, Reproduction.
[78] H. Rui,et al. Jak2/Stat5 Signaling in Mammogenesis, Breast Cancer Initiation and Progression , 2008, Journal of Mammary Gland Biology and Neoplasia.
[79] Richard A Gibbs,et al. Genomic analysis of the nuclear receptor family: new insights into structure, regulation, and evolution from the rat genome. , 2004, Genome research.
[80] G. Prins,et al. Molecular biology of the androgen receptor. , 2000, Mayo Clinic proceedings.
[81] W. Almawi,et al. Molecular mechanisms of glucocorticoid antiproliferative effects: antagonism of transcription factor activity by glucocorticoid receptor , 2002, Journal of leukocyte biology.
[82] R. Geney,et al. Advances in the discovery of selective JAK inhibitors. , 2013, Progress in medicinal chemistry.
[83] S. Catalano,et al. The multifactorial role of leptin in driving the breast cancer microenvironment , 2012, Nature Reviews Endocrinology.
[84] R. Levine,et al. JAK2 the future: therapeutic strategies for JAK-dependent malignancies. , 2012, Trends in pharmacological sciences.
[85] J. Fleet. Molecular actions of vitamin D contributing to cancer prevention. , 2008, Molecular aspects of medicine.
[86] D. Modi,et al. Progesterone activates Janus Kinase 1/2 and activators of transcription 1 (JAK1‐2/STAT1) pathway in human spermatozoa , 2013, Andrologia.
[87] E. Surmacz,et al. Leptin and cancer , 2006, Journal of cellular physiology.
[88] W. Wahli,et al. Peroxisome proliferator activated receptors: transcriptional regulators of adipogenesis, lipid metabolism and more.... , 1995, Chemistry & biology.
[89] M. Hou,et al. Altered p-JAK1 expression is associated with estrogen receptor status in breast infiltrating ductal carcinoma. , 2007, Oncology reports.
[90] S. Rane,et al. Janus kinases: components of multiple signaling pathways , 2000, Oncogene.
[91] D. Waxman,et al. Cross-talk between janus kinase-signal transducer and activator of transcription (JAK-STAT) and peroxisome proliferator-activated receptor-alpha (PPARalpha) signaling pathways. Growth hormone inhibition of pparalpha transcriptional activity mediated by stat5b. , 1999, The Journal of biological chemistry.
[92] S. Cl,et al. Intracellular signaling pathways: nongenomic actions of estrogens and ligand-independent activation of estrogen receptors. , 2001 .
[93] H. Tamura,et al. Hormonal modulation of peroxisomal enzyme induction caused by peroxisome proliferators: suppression by growth and thyroid hormones in cultured rat hepatocytes. , 1994, Archives of Biochemistry and Biophysics.